Λογότυπο www.galinos.gr Beta
 

Ιατροφαρμακευτική πληροφόρηση για τον επαγγελματία υγείας

Φάρμακα Δραστικές ουσίες Συμπληρώματα διατροφής Έλεγχος συγχορήγησης Νόσοι ICD-10
Κλαύδιος Γαληνός
Είσοδος χρηστών
Όνομα χρήστη
Συνθηματικό
Εικονίδιο Είσοδος χρήστη
Εικονίδιο Δωρεάν εγγραφή
Εικονίδιο Ανανέωση συνθηματικού

Ακολουθήστε μας Λογότυπο Facebook Λογότυπο Twitter

Αναζήτηση σε 63811 καταχωρήσεις
Εικονίδιο αναζήτησης

Βιβλιογραφική αναφορά

Προτάσεις

SPC, UK: Diamox Sodium 500mg Powder for Solution for Injection (2009)

Εκδότης

Εκδότης Mercury Pharma Group
Διεύθυνση No. 1 Croydon, 12 - 16 Addiscombe Road, Croydon, Surrey, CR0 0XT, UK
Σφάλμα Για την προβολή της πλήρους καταχώρησης χρειάζεται να έχετε συνδρομή σε ισχύ (αγορά συνδρομής).
Ολοκληρώνοντας τη διαδικασία δωρεάν εγγραφής θα αποκτήσετε, χωρίς καμία δέσμευση εκ μέρους σας, συνδρομή διάρκειας 30 ημερών.

Περιεχόμενα

Name of the medicinal product

DIAMOX® Sodium 500mg Powder for Solution for Injection Acetazolamide 500mg Powder for solution for Injection. ...

Qualitative and quantitative composition

Acetazolamide 500mg/vial. For excipients see 6.1.

Pharmaceutical form

Powder for solution for injection.

Therapeutic indications

Diamox is an enzyme inhibitor which acts specifically on carbonic anhydrase. It is indicated in the treatment ...

Posology and method of administration

Routes of Administration: Intravenous or intramuscular injection. The direct intravenous route is preferred ...

Contraindications

Acetazolamide is contraindicated in situations in which sodium and/or potassium blood levels are depressed, ...

Special warnings and precautions for use

Suicidal ideation and behaviour have been reported in patients treated with antiepileptic agents in several ...

Interaction with other medicinal products and other forms of interaction

DIAMOX is a sulphonamide derivative. Sulphonamides may potentiate the effects of folic acid antagonists. ...

Pregnancy and lactation

Acetazolamide has been reported to be teratogenic and embryotoxic in rats, mice, hamsters and rabbits ...

Effects on ability to drive and use machines

ncreasing the dose does not increase the diuresis and may increase the incidence of drowsiness and/or ...

Undesirable effects

Adverse reactions during short-term therapy are usually non-serious. Those effects which have been noted ...

Overdose

No specific antidote. Supportive measures with correction of electrolyte and fluid balance. Force fluids. ...

Pharmacodynamic properties

Acetazolamide is an inhibitor of carbonic anhydrase. By inhibiting the reaction catalysed by this enzyme ...

Pharmacokinetic properties

Acetazolamide has been estimated to have a plasma half-life of about 4 hours. It is tightly bound to ...

Preclinical safety data

Nothing of note to the prescriber.

List of excipients

Water for injection Sodium hydroxide Hydrochloric acid

Incompatibilities

None.

Shelf life

24 months.

Special precautions for storage

Do not store above 25ºC.

Nature and contents of container

Glass vial with butyl rubber plug and aluminium ring seal. Pack size 500mg vial.

Special precautions for disposal and other handling

Reconstitute each vial of DIAMOX Parenteral with at least 5ml of water for injection prior to use. The ...

Marketing authorization holder

Goldshield Pharmaceuticals Limited NLA Tower 12 – 16 Addiscombe Road Croydon Surrey CR0 0XT United Kingdom ...

Marketing authorization number(s)

PL 12762/0146

Date of first authorization / renewal of the authorization

11th February 1988 / 16th February 2004

Date of revision of the text

06/04/2009
Απαγορεύεται η αναπαραγωγή και αναδιανομή. Το έργο επεξεργασίας των παραπάνω πληροφοριών αποτελεί πνευματική ιδιοκτησία της Ergobyte Πληροφορική Α.Ε. και προστατεύεται από τη νομοθεσία περί πνευματικών δικαιωμάτων.